Functional diagnostics in non-small cell lung carcinoma - a new concept for the improvement of personalized therapy in Serbian patients
EXPANDing the value of Extracellular Vesicles as carriers of biomarker and therapy in precision healthcare
Development of nature-inspired photoresponsive anticancer agents - sclareol and artemisinin derivatives in cancer multidrug-resistance models: a foundation for the theranostic approach
Biomimetic tumor engineering to enhance drug discovery
Participation of SDIR at Cancer Metabolism Congress 2024
Enhancing non-communicable disease research excellence through zebrafish capacity building
Advancing REversible immunocapture toward SCALablE EV purification
Participation of SDIR at EACR 2024 Congress 10-13. June 2024
Twinning for a European Consortium of Rectal Cancer Research Institutions through Stepping Up Scientific, Technological and Innovation Excellence of IORS
Metabolic effects of bone marrow adipose tissue on multiple myeloma